Combinatorial 3D printed dosage forms for a two-step and controlled drug release.
Controlled drug release
FDM
Fused deposition modeling
Hybrid system
SLS
Selective laser sintering
Journal
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
ISSN: 1879-0720
Titre abrégé: Eur J Pharm Sci
Pays: Netherlands
ID NLM: 9317982
Informations de publication
Date de publication:
01 Aug 2023
01 Aug 2023
Historique:
received:
01
02
2023
revised:
15
05
2023
accepted:
02
06
2023
medline:
21
6
2023
pubmed:
6
6
2023
entrez:
5
6
2023
Statut:
ppublish
Résumé
Fused deposition modeling (FDM) and selective laser sintering (SLS) are two of the most employed additive manufacturing (AM) techniques within the pharmaceutical research field. Despite the numerous advantages of different AM methods, their respective drawbacks have yet to be fully addressed, and therefore combinatorial systems are starting to emerge. In the present study, hybrid systems comprising SLS inserts and a two-compartment FDM shell are developed to achieve controlled release of the model drug theophylline. Via the use of SLS a partial amorphization of the drug is demonstrated, which can be advantageous in the case of poorly soluble drugs, and it is shown that sintering parameters can regulate the dosage and release kinetics of the drug from the inserts. Furthermore, via different combinations of inserts within the FDM-printed shell, various drug release patterns, such as a two-step or prolonged release, can be achieved. The study serves as a proof of concept, highlighting the advantages of combining two AM techniques, both to overcome their respective shortcomings and to develop modular and highly tunable drug delivery devices.
Identifiants
pubmed: 37277047
pii: S0928-0987(23)00116-1
doi: 10.1016/j.ejps.2023.106486
pii:
doi:
Substances chimiques
Pharmaceutical Preparations
0
Theophylline
C137DTR5RG
Dosage Forms
0
Tablets
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
106486Informations de copyright
Copyright © 2023. Published by Elsevier B.V.
Déclaration de conflit d'intérêts
Declaration of Competing Interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Maria Stromme reports financial support was provided by Swedish Research Council. Maria Stromme reports financial support was provided by Sweden's Innovation Agency.